Malou C. Herman

No ORCID on file · 5 papers in corpus
other 2022
Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial
BMC women's health ·doi:10.1186/s12905-022-01843-6

BACKGROUND: It is estimated that between 12 to 25% of women who undergo an endometrial ablation for heavy menstrual bleeding (HMB) are dissatisfied after two years because of recurrent menstrual bleeding and/or cyclical pelvic pain, with ar…

observational 2021
Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding
BMC women's health ·doi:10.1186/s12905-021-01210-x

BACKGROUND: This study was conducted to identify factors that are associated with failure of treatment using the levonorgestrel releasing intrauterine system (LNG-IUS) in women with heavy menstrual bleeding. METHODS: For this study, data o…

2018
RCT COMPARING THE LNG-IUS VERSUS ENDOMETRIAL ABLATION IN WOMEN WITH HEAVY MENSTRUAL BLEEDING (MIRA)
other 2018
Women's preferences for the levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2018.06.020

OBJECTIVES: Women's preferences for treatment of heavy menstrual bleeding (HMB) are important in clinical decision-making. Our aim was to investigate whether women with HMB have a preference for treatment characteristics of the levonorgestr…

review 2016
Diagnosis of heavy menstrual bleeding
Women's health (London, England) ·doi:10.2217/whe.15.90

Heavy menstrual bleeding (HMB) is an important health problem. This paper gives an overview of the diagnosis of HMB. For each woman, a thorough history should be taken as one should ascertain whether there are underlying factors that could …